Insurance Risk - VOL. 6/NO. 7

A new hedging approach for Asian variable annuities

Market demand is driving insurance companies to offer variable annuities in Asia ex-Japan, despite the rough ride they received from their first steps into this market. Insurers are taking a more cautious approach to risk this time around, but have they…

The longevity challenge of care annuities

For most of the life industry, getting policyholder longevity predictions accurate to a few months of the realised experience would be cause for celebration. But for care annuity provider Partnership, this level of accuracy could be disastrous. Aaron…

Slovenia gears up for Solvency II challenge

In the last 20 years, the Slovene life industry has battled inflation rates of close to 2000%, sector-wide insolvency and is now readying for its first experience of risk-based capital regulation with the advent of Solvency II. Aaron Woolner reports

QIS 5 makes its mark

European insurers are gearing up to take part in Solvency II’s latest and final quantitative impact study. John Ferry assesses what the latest proposals suggest about the impact of the new regime

Insurers reappraise forex risk

Increasing currency volatility has prompted a reappraisal of insurers’ foreign exchange hedging approach – a phenomenon that will be accelerated, particularly in the Nordic regions, with the advent of Solvency II. Laurie Carver reports

Raj Singh interview: lesson for the future

The credit crisis has impacted the whole reinsurance sector, but, according to Raj Singh, chief risk officer at Swiss Re, at least it has taught the industry useful lessons for the future. Sarfraz Thind reports

MCEV – the quest for market consistency

After the extreme volatility of 2008 spoiled the MCEV launch party, investors have been understandably wary of the way some firms have taken a hardline stance on market consistency. Now the variance in how non-hedgable risks are assessed is what is…

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here